STEPHANIE FORTE DEESE: Open Payments
NPI 1093925695 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 19 payments from 8 companies in 2025. Trend: 2023 $373 · 2024 $302 · 2025 $554
Food & beverage: $356Education: $198
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $375 |
| Exeltis, USA Inc. | 4 | $70 |
| Hologic Sales and Service, LLC | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $15 |
Products named: Veozah, SLYND, APTIMA, GEMTESA, GARDASIL 9, QULIPTA, Qelbree, ZURZUVAE.
Industry payments across MD — which companies pay providers there.
